A deep learning method to predict bacterial ADP-ribosyltransferase toxins

Dandan Zheng1, Siyu Zhou1, Lihong Chen1

  • 1NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 102629, China.

Abstract

Insights

A new deep learning model, ARTNet, accurately identifies bacterial ADP-ribosyltransferase toxins (bARTTs) in genomes. This tool aids in discovering novel bARTTs, crucial for understanding bacterial virulence and pathogenesis.

Area of Science:

  • Biochemistry and Molecular Biology
  • Bioinformatics and Computational Biology
  • Microbiology

Background:

  • ADP-ribosylation regulates key cellular processes like chromatin structure, RNA transcription, and cell death.
  • Bacterial ADP-ribosyltransferase toxins (bARTTs) are vital virulence factors enabling bacteria to manipulate host cells for pathogenesis.
  • Identifying novel bARTTs is challenging due to limited data and sequence diversity.

Purpose of the Study:

  • To develop a deep learning model, ARTNet, for accurate prediction of bARTTs from bacterial genomes.
  • To overcome data scarcity and enhance prediction performance through data augmentation and domain subsequence utilization.

Main Methods:

  • Developed ARTNet, a deep learning model for bARTT prediction.
  • Implemented data augmentation techniques to address limited training data.
  • Utilized ART-related domain subsequences for optimized model performance.

Main Results:

  • ARTNet achieved high performance with an MCC of 0.9351 and F1-score (macro) of 0.9666 on independent test datasets.
  • ARTNet outperformed existing deep learning and traditional machine learning models in accuracy and efficiency.
  • Demonstrated ARTNet's capability to predict novel bARTTs across diverse superfamilies, even without sequence similarity.

Conclusions:

  • ARTNet is an effective tool for identifying novel bacterial ADP-ribosyltransferase toxins.
  • The model significantly advances the screening and discovery of bARTTs in bacterial genomics.
  • ARTNet is publicly available, facilitating broader research in bacterial pathogenesis and virulence.